Premium
Outcome analysis of laparoscopic incisional hernia repair and risk factors for hernia recurrence in liver transplant patients
Author(s) -
Weiss Sascha,
Weissenbacher Annemarie,
Sucher Robert,
Denecke Christian,
Brandl Andreas,
Messner Franka,
Oellinger Robert,
Schneeberger Stefan,
Schmid Thomas,
Pratschke Johann,
Biebl Matthias
Publication year - 2015
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.12558
Subject(s) - medicine , surgery , hernia , incisional hernia , body mass index , complication , abdominal hernia , abdominal wall , immunosuppression , general surgery
Incisional hernia is a common complication after liver transplantation (LT). Immunosuppression, obesity, and use of steroids are known risk factors. The purpose of the retrospective study was to summarize and evaluate experiences and results of laparoscopic intraperitoneal onlay mesh ( IPOM ) hernia repair. Methods We reviewed our liver transplant patients over a seven‐yr period with laparoscopic incisional hernia repair ( LIHR ) to direct our attention on risk factors for hernia recurrence after hernia repair. Results Fifty‐four patients after LT with incisional hernia were treated with laparoscopic repair, 42 male and 12 female patients of overall mean age of 58 ± 9 yr and body mass index (BMI) of 25 ± 4 kg/m 2 . A total of 755 LTs were performed at our institution in this time period, resulting in 7.15% of patients undergoing laparoscopic hernia repair. The mean postoperative hospital stay after was nine d. During the follow‐up, nine recurrent hernias were noted (17%). BMI (p = 0.001) and sirolimus as immunosuppressive therapy were significantly associated with hernia recurrence (p = 0.014). Conclusion LIHR is a safe and feasible method to treat hernias after LT. BMI and sirolimus as immunosuppressive therapy are risk factors for recurrence of hernia after laparoscopic hernia repair.